Product Name: Human MRC2 / CD280 Antibody (Quark patent anti-ENDO 180, Research Use)
Catalog Number: NBR-0823
Target Name: MRC2 / CD280
Trade Name: Quark patent anti-ENDO 180
Antibody Drug Description: The drug is a recombinant fully human anti-ENDO 180 monoclonal antibody, being developed by Quark. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name:  MRC2
Synonyms: CD280; CLEC13E; ENDO180; KIAA0709
Target Description: May play a role as endocytotic lectin receptor displaying calcium-dependent lectin activity. Internalizes glycosylated ligands from the extracellular space for release in an endosomal compartment via clathrin-mediated endocytosis.
Ensembl:  ENSG00000011028
Uniprot:  Q9UBG0